The Nelson Report

A new AI assistant is being piloted in the UAE, promising to cut doctor paperwork by 50% and give patients more face-to-face attention.

In a strategic move, industry leader Ashish Malik joins DunhamTrimmer's leadership, set to guide the firm's dominance in the booming biologicals market.

The digital signage firm's new virtual environment lets users explore a full installation, from emergency alerts to video walls, on any device.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

A new poll shows 81% of Americans fear tariffs will delay local projects, creating a funding crisis as costs rise and public opposition to new taxes grows.

A new VAB report alleges Nielsen's 'Big Data + Panel' currency is unstable and inaccurate, revealing massive audience variances that threaten media deals.

A new partnership uses licensed 5G spectrum to create a private highway for drones, promising unprecedented reliability for first responders and critical missions.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.

DoubleVerify's new partnership with TikTok promises deeper ad insights, but what does it signal for the future of platform transparency and ad spend?

A new report on 1 billion texts reveals when to send, what to say, and why SMS is beating email. Here's the data-driven strategy for 2026.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

As Thailand braces for another toxic smog season, air purifier giant Levoit deploys a timely strategy to capture a market born from a public health crisis.

As Malaysia's economic boom fuels urban traffic pollution, a new market for in-home health tech is emerging. Can companies like Levoit turn this risk into a strategic win?

Procyon Partners' largest acquisition yet pushes it to nearly $9B in assets, revealing a calculated strategy for national scale in a hot M&A market.

Prospect Enhanced Yield Fund's debut 9% distribution tempts income seekers, but a look into the structured credit market reveals a complex risk-reward.

The Dot Corp's new division signals a major shift in marketing logistics. Why are companies abandoning siloed vendors for a single source of truth?

An attack on a cat sparks a $10,000 reward, revealing a strategic model where non-profits invest in public safety to protect communities and assets.

Promising long-term data and key regulatory wins position Wugen's allogeneic therapy to disrupt the challenging T-cell cancer treatment landscape.

In a routine filing with major implications, Albion Crown VCT directors reinvest dividends, signaling deep faith in the VCT model as tax rules evolve.